Drugs
- Andexanet alfa (Andexxa)
- Apixaban (Eliquis)
- Betrixaban (Bevyxxa)
- Bivalirudin (Angiomax)
- Dabigatran (Pradaxa)
- Edoxaban (Savaysa)
- Fondaparinux (Arixtra)
- Heparin
- Idarucizumab (Praxbind)
- Low molecular weight heparins (LMWH)
- Rivaroxaban (Xarelto)
- Warfarin (Coumadin)
Conditions
- Monitoring Antithrombotic Therapy
- Anticoaguation and neuraxial anesthesia
- Bleeding Risk Assessment
- Central venous catheter management
- Chronic antithrombotic therapy
- Guidelines for reversal of anticoagulation
- Anticoagulant reversal for IPH
- Guidelines for Reversal of Anticoagulants
- Head injury in anticoagulated patients
- UW - CT Surgery Perioperative Hemostasis Plan
- Heparin-induced thrombocytopenia (HIT)
- Mechanical Circulatory Support
- Peri-procedural anticoagulation
- Anticoagulation around invasive procedures
- Anticoagulation around dental procedures
- Management of Antithrombotic Therapy for Chronic Pain Procedures
- Management of Antithrombotic Therapy for Neuraxial Procedures
- Perioperative Management of Antiplatelet Therapy
- VTE
- VTE prophylaxis
- DVT
- PE
- VTE Treatment
©2014 University of Washington